A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337
Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
This study is a randomized, open-label, single oral dose, 2-way crossover clinical trial to
compare safety and pharmacokinetics of CKD-337 in healthy male volunteers.